Effects of Royal Jelly Supplementation in Chronic Kidney Disease

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Kidney Failure, Chronic, Oxidative Stress, Hemodialysis

In brief

The objective of this study is to evaluate the effects of royal jelly on inflammation and cellular senescence in patients with chronic kidney disease (CKD) on hemodialysis (HD).

Key facts

Study ID

NCT06438445

Run by

Universidade Federal Fluminense

People needed

30

Starts

2024-07-30

Expected to finish

2027-04-05

Last updated by the study team

2026-05-18

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients with CKD undergoing hemodialysis for more than 6 months
• patients with arteriovenous fistula (AVF) as vascular access.

You may not qualify if…

• pregnant,
• lactating,
• smoker
• patients using antibiotics and antioxidant supplements in the last three months
• patients with autoimmune and infectious diseases,
• patients with cancer, liver disease, and AIDS

Where it is running

• Denise Mafra — Rio de Janeiro, Rio de Janeiro, Brazil (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.